Mrs. Sarah Kinns Esther, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 412 E Main St, Louisa, VA 23093 Phone: 540-967-0771 |
Dr. Sabrina Mawyer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 503 E Main St, Louisa, VA 23093 Phone: 540-967-0063 |
Dr. Christopher Robbs, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 412 E Main St, Louisa, VA 23093 Phone: 540-967-0771 |
Mrs. Donna Underwood Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 503 E Main St, Louisa, VA 23093 Phone: 540-967-0063 |
Adrian Webb Bakker, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 412 E Main St, Louisa, VA 23093 Phone: 540-967-0771 Fax: 540-967-4993 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, is reporting the filing of a complaint by Tekmira Pharmaceuticals Corporation in the Business Litigation Session (BLS) of the Massachusetts Superior Court. The complaint alleges misappropriation and misuse of information, amongst other allegations.
In the largest MRI study to date, researchers from Ben-Gurion University of the Negev and Carnegie Mellon University have shown that the brain anatomy in MRI scans of people with autism above age six is mostly indistinguishable from that of typically developing individuals and, therefore, of little clinical or scientific value.
In a collaborative effort, researchers from Boston University School of Medicine (BUSM) have discovered that deletions or mutations within the TFAP2A gene (Activating Enhancer-Binding Protein) result in the distinctive clefting disorder Branchio-Oculo-Facial syndrome (BOFS).
Researchers at the Centro Nacional de Investigaciones Cardiovasculares, working with an international network of scientists, have identified an inflammatory regulatory circuit in the eye controlled by a subtype of endothelial cells, the cells that line the interior of blood vessels.
Researchers from the Federal University of ParanĂ¡, Brazil, looked into the seroconversion rate after vaccination with the CoronaVac. Using immunoassays, they measured the immunoglobulins (IgG) for anti-nucleocapsid protein (anti-N) antibodies and anti-spike-1 (anti-S1) protein antibodies.
› Verified 7 days ago